Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine on Microcirculation in ESWL
NCT01179438Phase 4Withdrawn
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in nephrolithiasis, sponsored by National Taiwan University Hospital. Primary endpoint: Microcirculation status. Planned start Aug 2010; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT01179438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179438.